title: Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution.
abstract: ATP-dependent phosphoenolpyruvate carboxykinase (PEPCK) (ATP: oxaloacetate carboxylyase (transphosphorylating), EC 4.1.1.49) is a key enzyme involved in the catabolism of glucose and amino acids in the parasite Trypanosoma cruzi, the causative agent of Chagas' disease. Due to the significant differences in the amino acid sequence and substrate specificity of the human enzyme (PEPCK (GTP-dependent), EC 4.1.1.32), the parasite enzyme has been considered a good target for the development of new anti-chagasic drugs. We have solved the crystal structure of the recombinant PEPCK of T. cruzi up to 2.0 A resolution, characterised the dimeric organisation of the enzyme by solution small angle X-ray scattering (SAXS) and compared the enzyme structure with the known crystal structure of the monomeric PEPCK from Escherichia coli. The dimeric structure possesses 2-fold symmetry, with each monomer sharing a high degree of structural similarity with the monomeric structure of the E. coli PEPCK. Each monomer folds into two complex mixed alpha/beta domains, with the active site located in a deep cleft between the domains. The two active sites in the dimer are far apart from each other, in an arrangement that seems to permit an independent access of the substrates to the two active sites. All residues of the E. coli PEPCK structure that had been found to interact with substrates and metal cofactors have been found conserved and in a substantially equivalent spatial disposition in the T. cruzi PEPCK structure. No substrate or metal ion was present in the crystal structure. A sulphate ion from the crystallisation medium has been found bound to the active site. Solution SAXS data suggest that, in solutions with lower sulphate concentration than that used for the crystallisation experiments, the actual enzyme conformation may be slightly different from its conformation in the crystal structure. This could be due to a conformational transition upon sulphate binding, similar to the ATP-induced transition observed in the E. coli PEPCK, or to crystal packing effects. The present structure of the T. cruzi PEPCK will provide a good basis for the modelling of new anti-chagasic drug leads.
authors.affiliation: Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos-SP, Brasil.
authors.forename: S
authors.initials: S
authors.lastname: Trapani
authors.forename: J
authors.initials: J
authors.lastname: Linss
authors.forename: S
authors.initials: S
authors.lastname: Goldenberg
authors.forename: H
authors.initials: H
authors.lastname: Fischer
authors.forename: A F
authors.initials: AF
authors.lastname: Craievich
authors.forename: G
authors.initials: G
authors.lastname: Oliva
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D014355:Chagas Disease / Q000188:drug therapy; D003067:Coenzymes / Q000378:metabolism; D017124:Conserved Sequence; D003460:Crystallization; D019281:Dimerization; D015195:Drug Design; D004926:Escherichia coli / Q000201:enzymology; D008958:Models, Molecular; D008969:Molecular Sequence Data; D019764:Phosphoenolpyruvate Carboxykinase (ATP) / Q000037:antagonists & inhibitors / Q000737:chemistry*; D020836:Protein Structure, Quaternary; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D016415:Sequence Alignment; D013431:Sulfates / Q000378:metabolism; D014349:Trypanosoma cruzi / Q000201:enzymology*; D014961:X-Ray Diffraction
chemical_list: D003067:Coenzymes; D013431:Sulfates; D019764:Phosphoenolpyruvate Carboxykinase (ATP)